Matthew B Soellner Selected Research

Mitogen-Activated Protein Kinase Kinases (MEKs)

1/2021	Impact of between-tissue differences on pan-cancer predictions of drug sensitivity.
11/2020	MEK is a promising target in the basal subtype of bladder cancer.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.

Realize the full power of the drug-disease research graph!

Matthew B Soellner Research Topics

Disease

10	Neoplasms (Cancer) 12/2023 - 01/2007
3	Breast Neoplasms (Breast Cancer) 01/2023 - 12/2015
3	Triple Negative Breast Neoplasms 01/2020 - 10/2016
2	COVID-19 06/2023 - 03/2021
1	Brain Neoplasms (Brain Tumor) 01/2023
1	Urinary Bladder Neoplasms (Bladder Cancer) 11/2020
1	Neoplasm Metastasis (Metastasis) 01/2019

Drug/Important Bio-Agent (IBA)

4	Phosphotransferases (Kinase)IBA 01/2020 - 08/2012
2	Antiviral Agents (Antivirals)IBA 06/2023 - 03/2021
2	Mitogen-Activated Protein Kinase Kinases (MEKs)IBA 01/2021 - 11/2020
1	Proteolysis Targeting ChimeraIBA 12/2023
1	Complement System Proteins (Complement)IBA 01/2023
1	Messenger RNA (mRNA)IBA 01/2021
1	haloalkane dehalogenase (alkylhalidase)IBA 01/2021
1	Transcription Factors (Transcription Factor)IBA 01/2021
1	Drug CombinationsIBA 11/2020
1	Biomarkers (Surrogate Marker)IBA 01/2020
1	Vascular Endothelial Growth Factor A (Vascular Endothelial Growth Factor)IBA 01/2019
1	Interleukin-13IBA 01/2019
1	rho GTP-Binding Proteins (rho GTP-Binding Protein)IBA 01/2019
1	UM-164IBA 10/2016
1	lactimidomycinIBA 12/2015
1	Histone Deacetylase InhibitorsIBA 08/2013
1	Proteins (Proteins, Gene)FDA Link 08/2013
1	Phosphoribosylglycinamide FormyltransferaseIBA 01/2007
1	EnzymesIBA 01/2007

Therapy/Procedure

4	Therapeutics 01/2023 - 01/2019
2	Drug Therapy (Chemotherapy) 01/2023 - 01/2007
1	Precision Medicine 01/2023